Ajanta Pharma succeeds in revoking 2 Allergan patents

By: Pharma News | Views: 2301 | Date: 12-Aug-2013

In yet another landmark victory to the Indian patent scenario, Ajanta Pharma, a specialty focused pharmaceutical formulation company, emerged successful in revoking two composition patents of Allergan Inc. used for eye-related treatments.

Ajanta Pharma succeeds in revoking 2 Allergan patents




In yet another landmark victory to the Indian patent scenario, Ajanta Pharma, a specialty focused pharmaceutical formulation company, emerged successful in revoking two composition patents of Allergan Inc. used for eye-related treatments.

Ajanta had applied for revocation of both the patents under independent applications in 2011 on grounds of obviousness, not an invention, not patentable, insufficiency and non-disclosure under Section 8 of the Patents Act (2005) with Intellectual Property Appellate Board (IPAB). The combination patent decision has emerged as a landmark decision at IPAB.

Both the patents viz. IN 212695 and IN 219504 were granted by the Kolkata Patent Office in December 2007 and May 2008 respectively. IN 212695 was related to invention for the composition covering Bimatoprost and Timolol (GANFORT of Allergan) whereas IN 219504 was related to invention for the composition covering Brimonidine and Timolol (COMBIGAN of Allergan).

Ajanta filed revocation petitions with IPAB for both the patents believing that both these patents are invalid and unenforceable under IPA, 1970 and that these patents were granted on false representation. The IPAB, which has been constituted by the Central Government in the Ministry of Commerce and Industry to hear appeals against the decisions of the Registrar/Controller from the Patent & Trademark Offices and all appeals from various High Courts, rightly revoked both these patents on grounds of Obviousness and Breach of section (8) of IPA, 1970, as put forward by Ajanta.

Ajanta has already been successfully selling BIMAT T and BIDIN LS in Indian market and will continue to sell backed by this favourable verdict.

Ajanta Pharma has leading brands in therapeutic segments of ophthalmology, dermatology and cardiology.
Previous Page Next Page

People Searching On This Page:
  • bimatoprost formulation manufacturer india
  • operator
  • ajanta pharma patents
  • bimatoprost allergan india patent

Related Pages


Sun Pharma to buy 23% (USD 290 million) stake in Suzlon

Sun Pharma to buy 23% (USD 290 million) stake in Suzlon

News | Pharma Companies
Date:
03-Mar-2015  Views: 2956

Dilip Sanghvi, the founder of Sun Pharmaceutical Industries, has agreed to buy a 23 per cent stake in Indian wind turbine maker Suzlon Energy for abou ...
Pharma -Walk In on 15-05-2012 - Operator/Production/QA/QC/Eng.

Pharma -Walk In on 15-05-2012 - Operator/Production/QA/QC/Eng.

Jobs
Date:
08-May-2012  Views: 6633

K N M PharmaWe are fastest growing Pharma Company having WHO, GMP Approval with own manufactoring facilities at Moreiya Ahmedabad, along with PAN Indi ...
PTU Entrance Exam - 2012 B.Pharma/B.Tech

PTU Entrance Exam - 2012 B.Pharma/B.Tech

Articles | Exam & Results
Date:
15-Feb-2012  Views: 11397

Established in the year 1997 on the month of January, Punjab Technical University is the new face of advanced technical education functioning at brill ...
Influenza Virus Vaccine for the 2011 - 2012 Season

Influenza Virus Vaccine for the 2011 - 2012 Season

Articles | Pharmaceutical Drugs
Date:
10-Oct-2011  Views: 4925

Cumulative 2011/2012 Season Lot Release Status ...
GPAT Exam Syllabus 2012 - 2013

GPAT Exam Syllabus 2012 - 2013

Articles | Exam & Results | GPAT
Date:
07-Jul-2011  Views: 3982

Revised Syllabus Of GPAT 2012 - 2013Revised Syllabus Of GPAT 2012 Examination GPAT 2012 Syllabus Get Revised Updates about GPAT 2012 Syllabus ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

43  + 2 =     
Comments
People Searched About:
Bimatoprost Formulation Manufacturer India   |   Operator   |   Ajanta Pharma Patents   |   Bimatoprost Allergan India Patent   |  
Google : 181 times | Yahoo : 15 times | Bing : 102 times |